Premature Ovarian Failure (POF) Completed Phase 4 Trials for Ethinylestradiol (DB00977)

Also known as: Ovarian Failure, Premature / Premature Ovarian Failureļ¼Œ / Premature Ovarian Failure / Primary ovarian failure / Primary Ovarian Insufficiency / Female hypergonadotropic hypogonadism (disorder) / Hypergonadotrophic ovarian failure (disorder) / Premature ovarian failure (disorder) / Ovarian failure primary / Primary ovarian failure (disorder) / Premature menopause / Gonad failure: [other] or [testicular feminisation] or [hypogonadism - male] or [premature menopause] / Menopause, Premature / Menopause premature / Early menopause / Climacterium praecox / Premature menopause NOS (qualifier value) / Premature menopause NOS / Premature menopause (finding) / Secondary ovarian failure &/or premature menopause NOS / Menopause praecox (qualifier value) / Ovarian failure / Ovarian failure (disorder)

IndicationStatusPhase
DBCOND0053948 (Premature Ovarian Failure (POF))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00732693Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian FailureTreatment